Money and Finance
After spending the better part of last night watching the Star Wars trailer over and over I figured I'd better get around to posting about my latest purchase!
This time around I was trying to decide which stock to purchase and it came down to three stocks, IBM, PEP, and JNJ. I think that I would be happy with any of these stocks here and all three are due for dividend increases next quarter. Johnson & Johnson had recently announced it's earnings and over the next couple days the stock sold off just enough to trigger my limit order. In hindsight I wish I would have waited a day to buy since the markets got hammered down nearly 300 points on friday then I could have picked up shares a bit cheaper but ohh well.
I purchased 11 shares of Johnson & Johnson (JNJ) at $99.99
As with my last purchase of PM, JNJ also is facing currency headwinds from a strong dollar. This really showed in the quarterly numbers but I am confident the company will return to growth soon enough.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.
- After The Run Up There's Still Double Digit Return Potential For Johnson & Johnson
When you think of some of the greatest companies in the world one name that is sure to come up is Johnson & Johnson (NYSE:JNJ). What's not to like about a company that has earned investors 8.0% annualized total returns over the last decade, 10.8%...
- Johnson & Johnson: Quality At A Reasonable Price
I mentioned in my annual dividend growth checkup that I was underweight the health care industry and was looking to increase my exposure there. I recently added shares of one health care giant, Becton, Dickinson & Company (NYSE:BDX) (Full...
- Can Johnson & Johnson Cure What Ails Your Portfolio?
Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson & Johnson products in your medicine cabinet right now and if you've...
- September Dividend Update
As the market selloff continues we continue to see some great deals in the markets. I wish I had more money to take advantage of these low prices however we may see lower prices to come. I'll continue buying on the way down if we do. My most recent...
- Recent Buy - Johnson & Johnson
Earlier this week I purchased shares of Johnson & Johnson. I was having a tough time choosing between a few stocks on my watch list including PG, IBM, PEP and UL but ultimately went with JNJ. This monster of a company will continue to grow earnings...
Money and Finance
Recent Buy - Johnson & Johnson (JNJ)
This time around I was trying to decide which stock to purchase and it came down to three stocks, IBM, PEP, and JNJ. I think that I would be happy with any of these stocks here and all three are due for dividend increases next quarter. Johnson & Johnson had recently announced it's earnings and over the next couple days the stock sold off just enough to trigger my limit order. In hindsight I wish I would have waited a day to buy since the markets got hammered down nearly 300 points on friday then I could have picked up shares a bit cheaper but ohh well.
I purchased 11 shares of Johnson & Johnson (JNJ) at $99.99
As with my last purchase of PM, JNJ also is facing currency headwinds from a strong dollar. This really showed in the quarterly numbers but I am confident the company will return to growth soon enough.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.
Johnson & Johnson (JNJ) Stock Chart
Johnson & Johnson (JNJ) Basic Statistics
- Ticker Symbol: JNJ
- PE Ratio: 17.5 (15.5 Forward p/e)
- Sector: Healthcare
- Yield: 2.8%
- Dividend Growth Streak: 52 years
- 5 Year Dividend Growth Rate: 7.3%
- Payout Ratio: 48 %
- Market cap: $277b
- Beta: .96
- Website: http://www.jnj.com
Johnson & Johnson (JNJ) Dividend Growth Chart
Johnson & Johnson (JNJ) EPS Growth Chart
- After The Run Up There's Still Double Digit Return Potential For Johnson & Johnson
When you think of some of the greatest companies in the world one name that is sure to come up is Johnson & Johnson (NYSE:JNJ). What's not to like about a company that has earned investors 8.0% annualized total returns over the last decade, 10.8%...
- Johnson & Johnson: Quality At A Reasonable Price
I mentioned in my annual dividend growth checkup that I was underweight the health care industry and was looking to increase my exposure there. I recently added shares of one health care giant, Becton, Dickinson & Company (NYSE:BDX) (Full...
- Can Johnson & Johnson Cure What Ails Your Portfolio?
Johnson & Johnson (JNJ) is well known around the dividend growth investing community with over 50 consecutive years of dividend increases. Chances are there's Johnson & Johnson products in your medicine cabinet right now and if you've...
- September Dividend Update
As the market selloff continues we continue to see some great deals in the markets. I wish I had more money to take advantage of these low prices however we may see lower prices to come. I'll continue buying on the way down if we do. My most recent...
- Recent Buy - Johnson & Johnson
Earlier this week I purchased shares of Johnson & Johnson. I was having a tough time choosing between a few stocks on my watch list including PG, IBM, PEP and UL but ultimately went with JNJ. This monster of a company will continue to grow earnings...